Revolutionizing Diabetes Treatment: Dr. Yoshihara’s $3 Million Journey into Stem Cell Therapy
Pioneering Breakthroughs in Stem Cell Research Dr. Eiji Yoshihara of The Lundquist Institute has secured a $3 million NIH R01 grant to advance stem cell therapy for diabetes, focusing on human pluripotent stem cells (hPSCs) to develop functional islet cells. This research addresses the limitations of current treatments for insulin-dependent diabetes, offering hope beyond traditional […]